177 related articles for article (PubMed ID: 34561360)
21. Role of innate immunity in primary graft dysfunction after lung transplantation.
Diamond JM; Wigfield CH
Curr Opin Organ Transplant; 2013 Oct; 18(5):518-23. PubMed ID: 23995372
[TBL] [Abstract][Full Text] [Related]
22. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
Goldstein DR; Palmer SM
J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
[TBL] [Abstract][Full Text] [Related]
23. Alloimmune lung injury induced by local innate immune activation through inhaled lipopolysaccharide.
Garantziotis S; Palmer SM; Snyder LD; Ganous T; Chen BJ; Wang T; Cook DN; Schwartz DA
Transplantation; 2007 Oct; 84(8):1012-9. PubMed ID: 17989607
[TBL] [Abstract][Full Text] [Related]
24. Immune processes in the pathogenesis of chronic lung allograft dysfunction: identifying the missing pieces of the puzzle.
Bos S; Milross L; Filby AJ; Vos R; Fisher AJ
Eur Respir Rev; 2022 Sep; 31(165):. PubMed ID: 35896274
[TBL] [Abstract][Full Text] [Related]
25. The Microbiome, Systemic Immune Function, and Allotransplantation.
Nellore A; Fishman JA
Clin Microbiol Rev; 2016 Jan; 29(1):191-9. PubMed ID: 26656674
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota and its implications in small bowel transplantation.
Wang C; Li Q; Li J
Front Med; 2018 Jun; 12(3):239-248. PubMed ID: 29524068
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcomes and management of lung transplant recipients.
Costa J; Benvenuto LJ; Sonett JR
Best Pract Res Clin Anaesthesiol; 2017 Jun; 31(2):285-297. PubMed ID: 29110800
[TBL] [Abstract][Full Text] [Related]
28. Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation.
Methe H; Zimmer E; Grimm C; Nabauer M; Koglin J
Transplantation; 2004 Nov; 78(9):1324-31. PubMed ID: 15548971
[TBL] [Abstract][Full Text] [Related]
29. Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies.
DerHovanessian A; Wallace WD; Lynch JP; Belperio JA; Weigt SS
Semin Respir Crit Care Med; 2018 Apr; 39(2):155-171. PubMed ID: 29579768
[TBL] [Abstract][Full Text] [Related]
30. Role of donor macrophages after heart and lung transplantation.
Kopecky BJ; Frye C; Terada Y; Balsara KR; Kreisel D; Lavine KJ
Am J Transplant; 2020 May; 20(5):1225-1235. PubMed ID: 31850651
[TBL] [Abstract][Full Text] [Related]
31. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection.
Vos R; Vanaudenaerde BM; Verleden SE; Ruttens D; Vaneylen A; Van Raemdonck DE; Dupont LJ; Verleden GM
Transplantation; 2012 Jul; 94(2):101-9. PubMed ID: 22461039
[TBL] [Abstract][Full Text] [Related]
32. Innate immunity-mediated allograft rejection and strategies to prevent it.
Land WG
Transplant Proc; 2007 Apr; 39(3):667-72. PubMed ID: 17445569
[TBL] [Abstract][Full Text] [Related]
33. Novel Soluble Mediators of Innate Immune System Activation in Solid Allograft Rejection.
Usuelli V; Loretelli C; Seelam AJ; Pastore I; D'Addio F; Ben Nasr M; Fiorina P
Transplantation; 2022 Mar; 106(3):500-509. PubMed ID: 34049364
[TBL] [Abstract][Full Text] [Related]
34. Emerging science, emerging ethical issues: who should fund innate alloimmunity-suppressing drugs?
Land WG; Gutmann T; Daar AS
Acta Chir Belg; 2008; 108(1):73-82. PubMed ID: 18411578
[TBL] [Abstract][Full Text] [Related]
35. Gut microbes contribute to variation in solid organ transplant outcomes in mice.
McIntosh CM; Chen L; Shaiber A; Eren AM; Alegre ML
Microbiome; 2018 May; 6(1):96. PubMed ID: 29793539
[TBL] [Abstract][Full Text] [Related]
36. Ferroptosis in the post-transplantation inflammatory response.
Bai YZ; Kopecky BJ; Lavine KJ; Kreisel D
Cell Immunol; 2023; 393-394():104774. PubMed ID: 37839157
[TBL] [Abstract][Full Text] [Related]
37. An overview on non-T cell pathways in transplant rejection and tolerance.
Liu W; Li XC
Curr Opin Organ Transplant; 2010 Aug; 15(4):422-6. PubMed ID: 20531193
[TBL] [Abstract][Full Text] [Related]
38. The pulmonary microbiome: recent advances in understanding its role in chronic lung allograft dysfunction.
Mitchell AB; Glanville AR
Curr Opin Organ Transplant; 2022 Jun; 27(3):217-221. PubMed ID: 35649112
[TBL] [Abstract][Full Text] [Related]
39. Acute allograft failure in thoracic organ transplantation.
Jahania MS; Mullett TW; Sanchez JA; Narayan P; Lasley RD; Mentzer RM
J Card Surg; 2000; 15(2):122-8. PubMed ID: 11221970
[TBL] [Abstract][Full Text] [Related]
40. Immune mechanisms of lung allograft rejection.
Snyder LD; Palmer SM
Semin Respir Crit Care Med; 2006 Oct; 27(5):534-43. PubMed ID: 17072801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
